Literature DB >> 21598106

Prevalence of the NKG2D Thr72Ala polymorphism in patients with systemic lupus erythematosus.

Piotr Piotrowski1, Margarita Lianeri, Marzena Olesińska, Paweł P Jagodziński.   

Abstract

Multiple studies have indicated that SLE incidence exhibits a strong genetic background. We studied the frequency of the natural killer group 2, member D (NKG2D) receptor Thr72Ala (rs2255336) polymorphism in patients with SLE (n = 243) and controls (n = 502) in a sample of the Polish population. The p value for SLE patients with the Thr/Thr genotype was 0.0455 and Odds Ratio (OR) = 0.3846 (95% CI = 0.1458-1.014). For the Thr/Thr and Ala/Thr genotypes we found p = 0.0135 and OR = 0.6556 (95% CI = 0.4684-0.9177). The frequency of the NKG2D 72Thr allele in patients and controls was respectively, 15 and 21%, P = 0.0046, OR = 0.6547 (95% CI = 0.4877-0.8789). Our studies may confirm that the NKG2D 72Thr gene variant may protect against the incidence of SLE.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21598106     DOI: 10.1007/s11033-011-0868-1

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  39 in total

1.  Expansion of circulating NKG2D+ effector memory T-cells and expression of NKG2D-ligand MIC in granulomaous lesions in Wegener's granulomatosis.

Authors:  Dorin Capraru; Antje Müller; Elena Csernok; Wolfgang L Gross; Konstanze Holl-Ulrich; John Northfield; Paul Klenerman; Karen Herlyn; Julia Holle; Stefan Gottschlich; Jan Voswinkel; Thomas Spies; Ursula Fagin; Wolfram J Jabs; Peter Lamprecht
Journal:  Clin Immunol       Date:  2008-03-04       Impact factor: 3.969

2.  Conservation and variation in human and common chimpanzee CD94 and NKG2 genes.

Authors:  Benny P Shum; Laura R Flodin; David G Muir; Raja Rajalingam; Salim I Khakoo; Sophia Cleland; Lisbeth A Guethlein; Markus Uhrberg; Peter Parham
Journal:  J Immunol       Date:  2002-01-01       Impact factor: 5.422

3.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

4.  Cytokine production, serum levels and disease activity in systemic lupus erythematosus.

Authors:  G Gröndal; I Gunnarsson; J Rönnelid; S Rogberg; L Klareskog; I Lundberg
Journal:  Clin Exp Rheumatol       Date:  2000 Sep-Oct       Impact factor: 4.473

Review 5.  The curiously suspicious: a role for Epstein-Barr virus in lupus.

Authors:  J B Harley; I T W Harley; J M Guthridge; J A James
Journal:  Lupus       Date:  2006       Impact factor: 2.911

6.  Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX.

Authors:  Geoffrey Hom; Robert R Graham; Barmak Modrek; Kimberly E Taylor; Ward Ortmann; Sophie Garnier; Annette T Lee; Sharon A Chung; Ricardo C Ferreira; P V Krishna Pant; Dennis G Ballinger; Roman Kosoy; F Yesim Demirci; M Ilyas Kamboh; Amy H Kao; Chao Tian; Iva Gunnarsson; Anders A Bengtsson; Solbritt Rantapää-Dahlqvist; Michelle Petri; Susan Manzi; Michael F Seldin; Lars Rönnblom; Ann-Christine Syvänen; Lindsey A Criswell; Peter K Gregersen; Timothy W Behrens
Journal:  N Engl J Med       Date:  2008-01-20       Impact factor: 91.245

7.  A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease.

Authors:  Sophie Hüe; Jean-Jacques Mention; Renato C Monteiro; ShaoLing Zhang; Christophe Cellier; Jacques Schmitz; Virginie Verkarre; Nassima Fodil; Seiamak Bahram; Nadine Cerf-Bensussan; Sophie Caillat-Zucman
Journal:  Immunity       Date:  2004-09       Impact factor: 31.745

8.  A second lineage of mammalian major histocompatibility complex class I genes.

Authors:  S Bahram; M Bresnahan; D E Geraghty; T Spies
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

9.  Soluble MHC class I chain-related protein B serum levels correlate with disease activity in relapsing-remitting multiple sclerosis.

Authors:  Juan Luís Fernández-Morera; Sandra Rodríguez-Rodero; Carlos Lahoz; Alberto Tuñon; Aurora Astudillo; Olivia Garcia-Suarez; Jesús Martínez-Borra; Antonio López-Vázquez; Luis Rodrigo; Segundo Gonzalez; Carlos López-Larrea
Journal:  Hum Immunol       Date:  2008-04-07       Impact factor: 2.850

10.  Prevalence of ZAP-70, LAT, SLP-76, and DNA methyltransferase 1 expression in CD4+ T cells of patients with systemic lupus erythematosus.

Authors:  Radosław Januchowski; Mariusz Wudarski; Hanna Chwalińska-Sadowska; Paweł P Jagodzinski
Journal:  Clin Rheumatol       Date:  2007-05-11       Impact factor: 3.650

View more
  3 in total

1.  Association of NKG2D gene variants with susceptibility and severity of rheumatoid arthritis.

Authors:  C M Mariaselvam; R Tamouza; R Krishnamoorthy; D Charron; D P Misra; V K Jain; V S Negi
Journal:  Clin Exp Immunol       Date:  2016-12-18       Impact factor: 4.330

Review 2.  Regulation of NKG2D Stress Ligands and Its Relevance in Cancer Progression.

Authors:  Amber B Jones; Abbey Rocco; Lawrence S Lamb; Gregory K Friedman; Anita B Hjelmeland
Journal:  Cancers (Basel)       Date:  2022-05-09       Impact factor: 6.575

3.  Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients with Rheumatoid Arthritis.

Authors:  Milena Iwaszko; Jerzy Świerkot; Katarzyna Kolossa; Sławomir Jeka; Piotr Wiland; Katarzyna Bogunia-Kubik
Journal:  Genes (Basel)       Date:  2018-01-25       Impact factor: 4.096

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.